Potential new target for smoking cessation without weight gain – 3
Narrator: This is NIH Health Matters. I’m Joe Balintfy. A nicotine-like drug has shown a potential new target for smoking cessation without weight gain by specifically activating nicotine receptors in a brain center that controls feeding. Dr. Nora Volkow, an institute director at NIH explains.
Volkow: The research showed that stimulation of a nicotine receptor actually resulted in decrease for intake and loss of weight in animals that have been treated with this particular drug, which is called cytosine.
Narrator: Dr. Volkow points out that the drug in this study is available in Europe where it’s used for treatment of smoking cessation; but adds that more research is warranted. For information on this study, visit www.drugabuse.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.